AMERIPRISE FINANCIAL INC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$2,779,000
-79.4%
12,811
-89.0%
0.00%
-80.0%
Q4 2020$13,476,000
+20.9%
116,759
+2.0%
0.01%0.0%
Q3 2020$11,150,000
-23.7%
114,521
-3.9%
0.01%
-16.7%
Q2 2020$14,621,000
+77.5%
119,144
+26.7%
0.01%
+50.0%
Q1 2020$8,235,000
-3.8%
94,039
+14.8%
0.00%0.0%
Q4 2019$8,563,000
-71.8%
81,930
-69.0%
0.00%
-71.4%
Q3 2019$30,395,000
-41.9%
264,493
-12.9%
0.01%
-39.1%
Q2 2019$52,325,000
-21.3%
303,526
-23.1%
0.02%
-25.8%
Q1 2019$66,510,000
+73.3%
394,543
-0.2%
0.03%
+63.2%
Q4 2018$38,377,000
+294.6%
395,341
+602.2%
0.02%
+533.3%
Q3 2018$9,726,000
+15.2%
56,299
-7.3%
0.00%
-25.0%
Q2 2018$8,445,000
+87.1%
60,707
+51.6%
0.00%
+100.0%
Q1 2018$4,513,000
+28.7%
40,047
+50.8%
0.00%0.0%
Q4 2017$3,506,000
+34.0%
26,556
+3.0%
0.00%
+100.0%
Q3 2017$2,617,000
+1164.3%
25,791
+1149.6%
0.00%
Q2 2017$207,000
-10.0%
2,064
+8.5%
0.00%
Q1 2017$230,000
-82.2%
1,902
-80.4%
0.00%
-100.0%
Q3 2016$1,289,000
-16.4%
9,716
-42.0%
0.00%0.0%
Q2 2016$1,541,000
-2.6%
16,766
-23.5%
0.00%0.0%
Q1 2016$1,582,000
-59.7%
21,927
-61.2%
0.00%
-50.0%
Q4 2015$3,921,000
+52.3%
56,480
+100.3%
0.00%0.0%
Q3 2015$2,575,000
-28.2%
28,192
-3.4%
0.00%0.0%
Q2 2015$3,587,000
+21000.0%
29,193
+13353.0%
0.00%
Q3 2014$17,000
+13.3%
217
+47.6%
0.00%
Q2 2014$15,000
+150.0%
147
+58.1%
0.00%
Q1 2014$6,000930.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders